Sorafenib improves survival of FLT3-mutated acute myeloid leukemia in relapse after allogeneic stem cell transplantation: a report of the EBMT Acute Leukemia Working Party

Benzer Materyaller

• Sorafenib improves survival of FLT3-mutated acute myeloid leukemia in relapse after allogeneic stem cell transplantation: a report of the EBMT Acute Leukemia Working Party
  Yazar:: Ali Bazarbachi, ve diğerleri
  Baskı/Yayın Bilgisi: (2019-09-01)
• Allogeneic hematopoietic stem cell transplantation for isolated and leukemic myeloid sarcoma in adults: a report from the Acute Leukemia Working Party of the European group for Blood and Marrow Transplantation
  Yazar:: Patrice Chevallier, ve diğerleri
  Baskı/Yayın Bilgisi: (2011-09-01)
• Molecular Diagnosis of FLT3 Mutations in Acute Myeloid Leukemia Patients
  Yazar:: E. K. Zaikova, ve diğerleri
  Baskı/Yayın Bilgisi: (2020-04-01)
• Mixed phenotype acute leukemia: outcomes with allogeneic stem cell transplantation. A retrospective study from the Acute Leukemia Working Party of the EBMT
  Yazar:: Reinhold Munker, ve diğerleri
  Baskı/Yayın Bilgisi: (2017-12-01)
• CPX-351 in FLT3-mutated acute myeloid leukemia
  Yazar:: Claire Andrews, ve diğerleri
  Baskı/Yayın Bilgisi: (2023-11-01)